101 Startups
  • Sector
  • Participated in
  • Year of participation

Mercurna

  • 2016
  • Therapeutics
  • Venture Challenge
We firmly believe that everybody has the basic human right to live without the limitations of disease. Therefore, we aim to provide patients with new treatment options that add true value and allow them to break free from those limitations.

Mission MS

  • 2019
  • Therapeutics
  • Venture Challenge
From Genes to Pathways to Novel Drugs For Multiple Sclerosis

Momo Medical

  • Medical Device
  • Venture Challenge
Preventing pressure ulcers with smart monitoring

MULTISCREENING

  • 2019
  • Enabling Technology
  • Venture Challenge
At Multiscreening, we developed a patented technology to introduce High Throughput Screening (HTS) for in vivostudies, allowing our customers to increase patent protected market sales by 4 months for each animal experimental series being performed.

MyLife Technologies

  • 2010
  • Medical Device
  • Other
  • Venture Challenge
Nanoporous MicroNeedle Arrays (npMNAs), integrated into a patch for drug delivery through the skin

MyMicroZoo

  • 2016
  • Diagnostics
  • Venture Challenge
MyMicroZoo™ is a company that offers microbiome analysis and web-based tools to gather meta-data (e.g. age, health-status, exercise logs, etc.) as service to the general public, allowing them to gain knowledge and understanding of their microbiota through an innovative platform.

Myonovum

  • 2020
  • Enabling Technology
Humanised muscle models for preclinical testing - Leading in compound selection for neuromuscular disorders.

Ncardia

  • 2009
  • Enabling Technology
  • Venture Challenge
Stem cell technologies help bring better therapies to patients faster. Ncardia works with pharmaceutical and cell therapy companies worldwide to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities.